🔎 Trials Near Me

Gara Jalqabaatti › Baayyee Ulfaataa › California › San Diego

Qorannoo klinikaalii Baayyee Ulfaataa San Diego, CA keessatti

Qorannoo 13 Baayyee Ulfaataa f San Diego fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Namoota walitti qabaa jiraSadarkaa 3
  • Artemis Institute for Clinical Research, San Diego
  • Apex Clinical Research, San Diego
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684235

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Acclaim Clinical Research, San Diego
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • San Diego State University, San Diego
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05726942

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Namoota walitti qabaa jiraSadarkaa 3
  • Artemis Insitute for Clin Res, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07668414

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Namoota walitti qabaa jiraSadarkaa 3
  • Artemis Institute for Clinical Research, San Diego
  • Scripps Whittier Diabetes Institute, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07392190

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Artemis Institute for Clinical Research, LLC, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
  • ACCOMPLISH-2 Research Site, San Diego
  • ACCOMPLISH-2 Research Site, La Jolla · Miili 11 fagaatti
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07654374

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Namoota walitti qabaa jiraSadarkaa 3
  • Artemis Insitute for Clin Res, San Diego
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07571005

Effects of Watermelon or Low-fat Cookie Consumption on Wellness

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • School of Exercise and Nutritional Sciences, San Diego
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT06323070

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Namoota walitti qabaa jiraSadarkaa 3
  • Apex Clinical Research, San Diego
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Namoota walitti qabaa jiraSadarkaa 3
  • ACCOMPLISH-1 Research Site, San Diego
  • ACCOMPLISH-1 Research Site, La Jolla · Miili 11 fagaatti
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07654361

Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or Cancer

Namoota walitti qabaa jira
  • University of California San Diego, La Jolla · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT06824974

Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers

Namoota walitti qabaa jira
  • University of California San Diego Altman Clinical and Translational Research Institute, La Jolla · Miili 11 fagaatti
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 17-Mud-2025 · NCT06891352

Qorannoo Baayyee Ulfaataa magaalota biroo keessatti

Qorannoo biroo San Diego keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.